Italy could spend 1.5 billion euros on anti-Covid vaccines, all of Europe more than 11 billion: Report



[ad_1]

Italy could spend 1.5 billion euros on anti-Covid vaccines, and the whole of Europe more than 11 billion. The real cost of the vaccines purchased by the EU has been public since last night, albeit by mistake. Belgian Budget Minister Eva De Bleeker has posted on Twitter a table revealing the economic value of contracts signed by Brussels with pharmaceutical companies, so far kept secret due to strict confidentiality clauses.

The minister immediately deleted the post, but of course it was too late.

The table shows that the most expensive vaccines are precisely those from Pfizer / Biontech (12 euros per dose) and Moderna (18 dollars per dose), that is, the first pharmaceutical companies that were able to obtain approval from Ema, the European regulatory agency. . The least expensive is Astrazeneca, which had announced a “no profit” price. The company has not yet submitted a marketing application to the EMA, due to problems in conducting clinical trials.

It was Brussels that signed the contracts and set the prices, but the individual states would pay. And this is what the campaign envisaged in the government’s vaccine plan could cost Italy, divided by each individual pharmaceutical company

ASTRAZENECA – 40.38 million doses X 1.78 euros = 71,876,400 euro
NOT A WORD – 53.84 ml dose x $ 8.50 = 373,093,298.2 euro
PFIZER / BIONTECH 26.92 million doses x12 euros = 323,040,000 euro
SANOFI / GSK 40.38 million doses x 7.56 euros = 305,272,800 euro
CUREVAC 30,285 million doses x 10 euros = 302,850,000 euro
MODERN 10,768 million in doses x $ 18 = 158,015,985, 12 euros

total 202,573 million doses – cost 1,534,148,483.32 euros

Italy is responsible for 13.46% of the vaccines purchased by the EU, that is, 202.573 million doses. From what we can deduce that the entire EU will spend 11,397 million euros to buy 1,500 million doses. Of course, these figures could change if some of the vaccines do not pass the scrutiny of the EMA, the European regulatory agency. In that case, however, part of these resources would remain in the coffers of the pharmaceutical companies. The agreements signed with the companies establish that the EU assumes part of the risk of non-approval of medicines. How much remains a secret. Just as secret are the clauses that could exempt pharmaceutical companies from civil liability for any adverse vaccine event.

The service had taken care of the secrecy of the contracts signed with the pharmaceutical companies for the Covid vaccine: “The secrets of the chimpanzee virus“by Manuele Bonaccorsi.

Report issued on Monday at 9:20 p.m. on Rai3

[ad_2]